Biologics, Inc.
Cary, NC Doing business as Biologics By Mckesson Part of Mckesson Corporation
- UEI
- GVRYEDLFU6J3
- CAGE
- 6LEB9
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- Corporate family
-
-
Mckesson Corporation
Parent
S1RUKWWRYFL6
- Biologics, Inc. GVRYEDLFU6J3
-
Mckesson Corporation
Parent
S1RUKWWRYFL6
- SAM.gov registration date
- Physical address
- 11800 Weston Pkwy, Cary, NC 27513, USA
- Website
- mckesson.com
- Founded
- 1833
- Employees
- 50K-100K
- Estimated annual revenue
- $10B+
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Specialty medication | Federal Correctional Complex Butner | $286,308 | |
| Lenalidomide 15MG, 10MG ndcs: 76282-0699-47, 76282-0698-48 | Veterans Integrated Service Network 21 | $29,628 | |
| Lenalidomide 5MG NDC: 76282-0697-48 | Veterans Integrated Service Network 21 | $18,697 | |
| Cancer drug biologics (mckesson) sept order FY25 | Federal Medical Center Carswell | $22,061 | |
| Lenalidomide | Veterans Integrated Service Network 21 | $77,456 |
About Biologics, Inc.
Biologics, Inc., doing business as Biologics By McKesson, operates as a for-profit pharmaceutical distributor supplying specialty cancer medications and biologics to federal healthcare and correctional facilities as a prime contractor, leveraging its position as a subsidiary of McKesson Corporation. Biologics competes exclusively in full-and-open procurements with no set-aside designations across 178 awards with combined potential value of $3.2 million.
The vendor's capability portfolio centers on specialty pharmaceutical supply: Lenalidomide (for multiple myeloma and lymphomas), Turalio (pexidartinib, a tyrosine kinase inhibitor for tenosynovial giant cell tumors), Caprelsa (vandetanib, a kinase inhibitor for medullary thyroid cancer), Ayvakit, and Xermelo, delivered through firm fixed-price purchase orders. Representative prime awards include a $286 thousand specialty medication contract with Federal Correctional Complex Butner (April 2026), multiple Lenalidomide orders to Veterans Integrated Service Network 21 totaling approximately $126 thousand (September–December 2025), and recurring monthly cancer drug biologics purchase orders to Federal Medical Center Carswell at $22 thousand per order (October 2024–May 2025).
Customer concentration is split between the Department of Veterans Affairs and the Department of Justice Bureau of Prisons, accounting for 51% of awards by count and 57% by potential value. Veterans Integrated Service Network 19 leads with 34 awards and $493 thousand combined potential value, followed by Federal Medical Center Lexington (14 awards, $490 thousand) and Federal Correctional Complex Butner (8 awards, $359 thousand). The vendor holds no parent contract vehicles; all work flows through direct purchase orders to individual federal healthcare and correctional institutions. Activity averaged roughly two to four awards annually from 2023 to 2024, then increased to 13 awards in 2025; one award has closed in 2026. Only one award (the April 2026 Federal Correctional Complex Butner order) reaches ultimate completion within the next twenty-four months, representing $286 thousand in recompete exposure.
Biologics operates as a wholly owned subsidiary of McKesson Corporation, a major healthcare services and IT provider that holds its own indefinite-delivery contracts with federal agencies including the Indian Health Service and the Department of Veterans Affairs. All 178 awards in Biologics' portfolio are prime awards; the vendor does not subcontract. Place of performance is listed as Cary, North Carolina, matching Biologics' headquarters address.
Quick answers
What is Biologics, Inc.'s UEI?
Biologics, Inc.'s Unique Entity ID (UEI) in SAM.gov is GVRYEDLFU6J3.
What is Biologics, Inc.'s CAGE code?
Biologics, Inc.'s CAGE code is 6LEB9.
What is Biologics, Inc.'s primary NAICS code?
Biologics, Inc.'s primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).
Where is Biologics, Inc. located?
Biologics, Inc.'s physical address in SAM.gov is 11800 Weston Pkwy, Cary, NC 27513, USA.
Is Biologics, Inc. registered in SAM.gov?
Yes. Biologics, Inc.'s SAM.gov registration is active through September 23, 2027.
Who is Biologics, Inc.'s parent company?
Biologics, Inc. is part of Mckesson Corporation.
What is Biologics, Inc.'s most recent federal award?
Biologics, Inc.'s most recent federal contract award is Specialty medication (15B10626P00000273), from Federal Correctional Complex Butner, on April 3, 2026.
On GovTribe
See Biologics, Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors